Position in AKBA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$158,524
-$153,856 QoQ
Shares Held
114,047
-41.2% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 7%
Shared 0%
None 93%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $2,051,605,339 across 61 Drug Manufacturers - Specialty & Generic names. AKBA ranks #38 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
5,442,067 | $716,937,900 | |
| 2 | ZTS |
Zoetis Inc.
|
3,387,174 | $400,397,831 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,762,744 | $203,693,847 | |
| 4 | ALKS |
Alkermes plc.
|
4,101,789 | $145,039,257 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
5,240,816 | $108,799,337 | |
| 6 | HLN |
Haleon plc
|
8,279,468 | $82,877,469 | |
| 7 | VTRS |
Viatris Inc
|
5,731,565 | $77,433,437 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
4,371,378 | $60,543,580 |
All Filings in AKBA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $158,524 | 114,047 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $312,380 | 194,026 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,714,113 | 994,181 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $6,015,994 | 1,652,746 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,423,027 | 741,161 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $866,957 | 456,294 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $130,079 | 98,546 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $90,661 | 88,884 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $422 | 231 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $286 | 231 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $108,127 | 94,849 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $34,680 | 37,903 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $45,665 | 81,547 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $2 | 4,044 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,599 | 11,391 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,548 | 7,220 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $3,057,384 | 4,258,198 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $10,016,776 | 4,432,203 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $13,149,315 | 4,565,735 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $18,752,072 | 4,947,777 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $4,072,210 | 1,203,017 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,084,706 | 1,458,824 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $572,156 | 227,951 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,175,042 | 233,803 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $3,638,375 | 479,997 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||